Heejung Kim

8PUBLICATIONS
13CO-AUTHORS
Molecular targetsPlant pathologyCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 29, 2025
IA-0130, a novel 3-(1,3-diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL-6/gp130/STAT3 signalling.

Sun-Ae Park, Hee Jung Kim, Lee Kyung Kim

|Jul 13, 2024
IL-6 Inhibitory Compounds from the Aerial Parts of Piper attenuatum and Their Anticancer Activities on Ovarian Cancer Cell Lines.

Hye Jin Kim, Lee Kyung Kim, Anna Kim

|May 16, 2023
LncRNA SNHG4 Modulates EMT Signal and Antitumor Effects in Endometrial Cancer through Transcription Factor SP-1.

Lee Kyung Kim, Sun-Ae Park, Eun Ji Nam

|Apr 13, 2023
Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human Ovarian Cancer and by Regulation of the IL-6/STAT3/FoxO3a Pathway.

Sun-Ae Park, Young Ju Seo, Lee Kyung Kim

|Aug 27, 2021
Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer.

Leekyung Kim, Sun-Ae Park, Hyemin Park

|Aug 17, 2021
LncRNA SRA mediates cell migration, invasion, and progression of ovarian cancer via NOTCH signaling and epithelial-mesenchymal transition.

Lee Kyung Kim, Sun-Ae Park, Yoolhee Yang

Pageof 2

Frequent Collaborators

4 joint publications

Leekyung Kim

3 joint publications

Young Tae Kim

3 joint publications

Sun-Ae Park

1 joint publications

Kyung Jin Eoh